Steroid-Induced Bone Loss Is the Second Most Common Cause of Osteoporosis

NOVEMBER 14, 2016
Amy Jacob

Nancy Lane, MD, shared a rheumatologist's perspective in treating patients who suffer pain and osteoporosis. While she and other experts use many medications to treat osteoporosis, there aren't very many right now. As such, Lane believes they need more medications that willincrease bone mass, and is hoping abaloparatide, if approved and safe, can be welcomed as a new treatment for osteoporosis.  "We're very excited. My colleagues and I are quite hopeful to get the announcement that the medication abalaparatide is approved by the FDA, so that we can help our patients."

Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.